US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

UTHR United Therapeutics Corporation

311.02

-6.85 (-2.15%)

Última actualización: 09:10:49

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/08/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Nilda Mesa

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

United Therapeutics (NASDAQ:UTHR)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025

Haga Click aquí para más Gráficas United Therapeutics.

United Therapeutics (NASDAQ:UTHR)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025

Haga Click aquí para más Gráficas United Therapeutics.

Noticias sobre United Therapeutics Corporation UTHR

Form 144 - Report of proposed sale of securities
Lunes 10 de Marzo 2025 (18 horas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Viernes 7 de Marzo 2025 (4 días hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martes 4 de Marzo 2025 (7 días hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 3 de Marzo 2025 (1 semana hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Viernes 28 de Febrero 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Viernes 28 de Febrero 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Miércoles 26 de Febrero 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Miércoles 26 de Febrero 2025 (2 semanas hace) • Edgar (US Regulatory)

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
Miércoles 26 de Febrero 2025 (2 semanas hace) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Martes 25 de Febrero 2025 (2 semanas hace) • Edgar (US Regulatory)

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference
Lunes 24 de Febrero 2025 (2 semanas hace) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Viernes 21 de Febrero 2025 (3 semanas hace) • Edgar (US Regulatory)

Más de United Therapeutics Corporation Artículos de Noticias

JP Morgan Chase

Deutsche Telekom (QX)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones